Salute e Benessere

WELLA PROFESSIONALS NAMED AS OFFICAL PARTNER OF F1 ACADEMY™

Beginning with Round 4 at the FORMULA 1 PIRELLI GRAND PRIX DU CANADA 2025, Wella Professionals will be proudly represented on the F1 ACADEMY grid by Joanne Ciconte, in the Wella Professionals operated by MP car. Wella's bespoke livery coincides with the launch of the brand's new global campaign Make It You, which encourages people to define beauty on their own terms while championing self-expression through limitless creativity. Beginning with Round 4 at the FORMULA 1 PIRELLI GRAND PRIX DU...
PR Newswire
11/06/2025

Oral Iron Supplements Market to Reach USD 4,128.06 Million by 2032, Driven by…

Product innovation remains a central focus, with manufacturers introducing enhanced formulations aimed at improving absorption and minimizing gastrointestinal side effects. The availability of over-the-counter (OTC) options, along with growing interest in plant-based and vegan supplements, is further accelerating consumer adoption. With expanding distribution networks across retail pharmacies and online platforms, the market is set to benefit from robust demand in both developed and emerging…
PR Newswire
11/06/2025

Northwest Biotherapeutics Announces Upcoming Presentation On Next Generation…

About Northwest Biotherapeutics About Northwest Biotherapeutics Northwest Biotherapeutics is a biotechnology company focused on developing personalized immunotherapy products that are designed to treat cancers more effectively than current treatments, without toxicities of the kind associated with chemotherapies, and on a cost-effective basis. The Company has a broad platform technology for DCVax ® dendritic cell-based vaccines. The Company's lead program involves DCVax ® -L treatment...
PR Newswire
11/06/2025

KFSHRC First in the Middle East to Implant AI-Powered Brain-Sensing Device for…

RIYADH, Saudi Arabia, June11, 2025(GLOBE NEWSWIRE) -- In a landmark medical achievement, King Faisal Specialist Hospital & Research Centre (KFSHRC) has become the first institution in the Middle East to successfully implant an AI-powered brain-sensing device designed for the treatment of complex neurological disorders. The breakthrough ushers in a new era of real-time, adaptive neuromodulation therapy, offering renewed hope for patients suffering from Parkinson’s disease, epilepsy,...
Nasdaq GlobeNewswire
11/06/2025

ONWARD Medical Announces Results of its Annual General Meeting of Shareholders

THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014)Shareholders approve all proposed resolutionsEINDHOVEN, The Netherlands, June11, 2025(GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD and US OTCQX: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function and independence in people with spinal cord injury and other movement disabilities, today announces that...
Nasdaq GlobeNewswire
11/06/2025

ADJOURNMENT OF THE GENERAL MEETING INITALLY CONVENED ON JUNE 25, 2025

ADJOURNMENT OF THE GENERAL MEETING INITALLY CONVENED ON JUNE 25, 2025NANTES, France, June 11, 6:30 PM – OSE ImmunotherapeuticsSA(ISIN: FR0012127173; Mnemo: OSE), announces the cancellation of the convening of the mixed General Meeting initially scheduled for June 25, 2025 (the « General Meeting ») to clarify the situation. The Board of Directors will convene a new General Meeting within the allotted time frame.Following the publication on June 3, 2025, of a concerted declaration on...
Nasdaq GlobeNewswire
11/06/2025

Oxurion Receives Transparency Notifications from Atlas Special Opportunities II…

Leuven, BELGIUM – June 11, 2025 – 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency legislation1 it has received transparency notifications as follows: Oxurion received a transparency notification on June 9, 2025, from Atlas Special…
Actusnews Wire
11/06/2025

Medical Tapes and Bandages Market Size worth $9.86 billion, Globally, by 2030 -…

For More Information and To Stay Updated on The Latest Developments in The Medical Tapes and Bandages Market Share, Download FREE Sample Pages: https://www.theresearchinsights.com/request_sample?id=10080 For More Information and To Stay Updated on The Latest Developments in The Medical Tapes and Bandages Market Share, Download FREE Sample Pages: https://www.theresearchinsights.com/request_sample?id=10080 Market Overview and Growth Trajectory: Medical Tapes and Bandages Market...
PR Newswire
11/06/2025

Pharming Group reports on results of the 2025 Annual General Meeting of…

Leiden, the Netherlands, June 11, 2025: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext Amsterdam: PHARM / Nasdaq: PHAR) announces that at its Annual General Meeting of Shareholders (AGM) held today, all proposals were approved.Dr. Elaine Sullivan, a seasoned leader in the international pharmaceutical and biotech industry with deep R&D expertise and public non-executive board experience, was appointed to the Pharming Board of Directors, upon binding recommendation of the...
Nasdaq GlobeNewswire
11/06/2025

Home Healthcare Market Share Worth $666.91 billion, Globally, by 2030 -…

For More Information and To Stay Updated on The Latest Developments in The Global Home Healthcare Market Size, Download FREE Sample Pages: https://www.theresearchinsights.com/request_sample?id=1372 For More Information and To Stay Updated on The Latest Developments in The Global Home Healthcare Market Size, Download FREE Sample Pages: https://www.theresearchinsights.com/request_sample?id=1372 Market Overview and Growth Trajectory: Home Healthcare Market Growth: According...
PR Newswire
11/06/2025

Cannabidiol Market Size worth $22.05 billion, Globally, by 2030 - Exclusive…

For More Information and To Stay Updated on The Latest Developments in The Global Cannabidiol Market Share, Download FREE Sample Pages: https://www.theresearchinsights.com/request_sample?id=10131 For More Information and To Stay Updated on The Latest Developments in The Global Cannabidiol Market Share, Download FREE Sample Pages: https://www.theresearchinsights.com/request_sample?id=10131 Market Overview and Growth Trajectory: Cannabidiol Market Growth: According to an...
PR Newswire
11/06/2025

22.2% CAGR, Digital Health Market Size Worth $946.04 Billion Growth, Globally…

For More Information and To Stay Updated on The Latest Developments in The Global Digital Health Market Trends, Download FREE Sample Pages: https://www.theresearchinsights.com/request_sample?id=216 For More Information and To Stay Updated on The Latest Developments in The Global Digital Health Market Trends, Download FREE Sample Pages: https://www.theresearchinsights.com/request_sample?id=216 Market Overview and Growth Trajectory: Digital Health Market Growth: According...
PR Newswire
11/06/2025

Dental Soft-tissue Regeneration Market worth $0.53 billion in 2030 with 6.8%…

Browse in-depth TOC on "Dental Soft-tissue Regeneration Market" Browse in-depth TOC on "Dental Soft-tissue Regeneration Market" 300 - Tables50 - Figures330 - Pages By Based on product type,the collagen-based membrane segment holds the largest share of the dental soft-tissue regeneration market. These membranes, derived from natural sources such as bovine or porcine collagen, closely resemble the extracellular matrix of human tissues. This resemblance promotes cell...
PR Newswire
11/06/2025

Wandercraft announces Series D Round, bringing $75M in total funding secured for…

Clinical progress, industrial partnerships, and global recognition drive momentum in rehabilitation, personal mobility, and humanoid robotics.New agreement with Renault Group accelerates commercialization and advances Wandercraft’s global robotics footprint.NEW YORK, June11, 2025(GLOBE NEWSWIRE) -- Wandercraft, the global leader in self-balancing robotic mobility systems, today announced that it has secured $75 million funding and financing as part of its Series D round, with...
Nasdaq GlobeNewswire
11/06/2025

OKYO Pharma to Present at the Bio International Convention

LONDON and NEW YORK, June11, 2025(GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ:OKYO ), a clinical-stage biopharmaceutical company developing innovative therapies for the treatment of neuropathic corneal pain, a severe ocular condition without an FDA approved therapy, and for inflammatory eye diseases, announced that its CEO, Gary S. Jacob, Ph.D., will be giving an oral presentation during the Bio International Convention in Boston, MA. Dr. Jacob’s presentation will cover the...
Nasdaq GlobeNewswire
11/06/2025

uniQure Announces Appointment of Kylie O’Keefe as Chief Customer and Strategy…

~ Proven biotech executive to lead commercialization of AMT-130 in Huntington’s disease ~ LEXINGTON, Mass. and AMSTERDAM, June11, 2025(GLOBE NEWSWIRE) --uniQureN.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced the appointment of Kylie O’Keefe as Chief Customer and Strategy Officer, effective June 6, 2025. In this role, Ms. O’Keefe will lead the development and execution of uniQure’s global...
Nasdaq GlobeNewswire
11/06/2025

Chiesi Group Enters into Worldwide Licensing Agreement with Key2Brain AB to…

Collaboration will leverage Key2Brain’s technology to develop blood-brain barrier-crossing enzyme replacement therapies for lysosomal storage disordersAgreement is built on a partnership initiated 2022, supporting continued development led by positive in vivo proof-of-concept data demonstrating the potential of Key2Brain's technology PARMA, Italy and STOCKHOLM, June11, 2025(GLOBE NEWSWIRE) -- Chiesi Group and Key2Brain today announced a worldwide license agreement to advance the...
Nasdaq GlobeNewswire
11/06/2025

Ping An Good Doctor Revamps Brand and Launches Annual Healthcare Service Brand

During the launch, Mr. Li Dou, Chairman and CEO of Ping An Good Doctor, delivered a speech on the rationale and implications of the company's brand upgrade. Professor Li Yexiong, Director of the Department of Radiation Oncology at the Cancer Hospital Chinese Academy of Medical Sciences and President of Cancer Hospital Chinese Academy of Medical Sciences Henan Hospital, as well as Chairman of the Chinese Society of Clinical Oncology (CSCO) Radiation Therapy Committee; and Dr. Tao Yong, Director…
PR Newswire
11/06/2025

Medtech Industry Establishes Foundation for Clinical Trials with Veeva MedTech

With a growing number of medical device and diagnostic clinical trials executed on Veeva Clinical applications, companies can gain the scalability to grow while maintaining compliance with local, regional, and global regulations. Medtechs of all sizes use Veeva to drive improvements, with customers achieving 50% faster study build times with Veeva EDC and 80% reductions in duplicate trial documents with Veeva eTMF. With a growing number of medical device and diagnostic clinical trials…
PR Newswire
11/06/2025

Novo Nordisk selects Gefion AI Supercomputer to advance drug discovery and…

"Working alongside Novo Nordisk, we can use Gefion to redefine what is possible in drug research," said Nadia Carlsten, CEO of DCAI. "With Gefion's computational power, we can tackle the toughest R&D challenges, with the ultimate goal of delivering actionable insights that can shave months off development timelines and unlock new possibilities for pharmaceutical research and development." "Working alongside Novo Nordisk, we can use Gefion to redefine what is possible…
PR Newswire
11/06/2025

Introducing FactsR™ by Corti -- the First Clinical Reasoning Layer for Ambient…

Unlike traditional LLM pipelines retrofitted for healthcare, FactsR is powered by Corti's recursive fact-first reasoning loop - a purpose-built engine designed to surface, validate, and structure clinical knowledge in real time as conversations unfold. Delivered as a modular API, it enables developers to embed clinical-grade intelligence directly into their healthcare applications - creating safer, leaner, and more trusted AI experiences at the point of care. Unlike traditional LLM pipelines...
PR Newswire
11/06/2025

Deep Apple Therapeutics Announces Collaboration with Novo Nordisk to Discover…

SOUTH SAN FRANCISCO, Calif., June 11, 2025 /PRNewswire/ -- Deep Apple Therapeutics, Inc. announced today a research collaboration and exclusive worldwide license agreement with Novo Nordisk to discover, develop, and commercialize oral small molecule therapeutics directed at a novel non-incretin GPCR target for cardiometabolic diseases, including obesity. SOUTH SAN FRANCISCO, Calif. , June 11, 2025 /PRNewswire/ -- Deep Apple Therapeutics, Inc. announced today a research collaboration and...
PR Newswire
11/06/2025

Lembas Emerges from Stealth with Breakthrough Discovery in Natural GLP-1 for…

Nearly 75% of US adults are overweight or obese*, but the new GLP-1 pharmaceuticals are out of reach for many due to lack of accessibility, prohibitive costs, and severe side effects. This creates an urgent opportunity for the food and supplements industries to provide evidence-based solutions that help consumers manage their weight more naturally and effectively. Lembas is pioneering the next generation of science-backed bioactive ingredients for the functional food and supplements...
PR Newswire
11/06/2025

Spring Bio Solution Launches NCE Grid to decode Para IV Filing and First-to-File…

clinical trial supplies, has launchedNCE Grid, the world’s first freeNCE-1 intelligence platform- built to decode, centralize, and visualize Para IV and NCE-1 opportunities in real-time.Until now, tracking NCE exclusivity expirations andParagraph IV filingshas been a fragmented, manual, and cumbersome process, lacking a centralized solution. Regulatory updates are scattered across various portals, intelligence is buried in siloed databases, and timelines are tracked using...
Nasdaq GlobeNewswire
11/06/2025
Altri  Comunicati